Roche

Principal Partner

Information

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Patients with hepatocellular carcinoma (HCC) have two diseases in one organ: firstly, the underlying liver disease and, secondly, the HCC tumour. Both liver diseases cause a significant burden for the patient and may impact associated treatment. Together with partners, Roche aims to stop the progression of chronic liver disease and, one day, even cure HCC with interventions across detection, prevention and treatment. By rethinking the disease from every possible angle and developing integrated solutions, this new era of partnership and innovation can improve the lives of millions of people around the world.

Disclaimer
This content is intended only for physicians practising outside the USA.

Social media

Contact details

Sessions

Documents & Links

Log in